Literature DB >> 11369706

Discordant cellular and humoral immune responses to cytomegalovirus infection in healthy blood donors: existence of a Th1-type dominant response.

J Zhu1, G M Shearer, F M Marincola, J E Norman, D Rott, J P Zou, S E Epstein.   

Abstract

Previous studies have documented discordant cellular and humoral immune responses to subjects exposed to HIV-1, and that the nature of such responses may determine susceptibility and resistance to disease. We determined whether there is a spectrum of cellular versus humoral immunodominant responses to cytomegalovirus (CMV) infection. Blood samples from 50 healthy blood donors were tested for anti-CMV IgG antibodies and for proliferative responses of peripheral blood mononuclear cells (PBMC) to CMV antigens. Four patterns of immune responses to CMV were found: no detectable response (30%, Ab(-)/Tc(-)), anti-CMV IgG only (28%, Ab(+)/Tc(-)), both anti-CMV IgG and T lymphocyte proliferation to CMV antigens (18%, Ab(+)/Tc(+)), and, interestingly, T lymphocyte proliferation to CMV only (24%, Ab(-)/Tc(+)). To determine whether these immunodominant phenotypes correlate with the ability of PBMC to secrete IL-2 and IFN-gamma in response to CMV antigens, we found that a greater percentage of individuals with a T cell proliferative response to CMV antigens (Ab(-)/Tc(+) and Ab(+)/Tc(+)) responded with increased IL-2 (P = 0.001) and IFN-gamma levels (P = 0.002), compared to those without a proliferative response (Ab(-)/Tc(-) and Ab(+)/Tc(-)). Our data therefore demonstrate that different individuals exhibit different immunodominant patterns of response to CMV. In particular, some individuals who are exposed to CMV fail to develop an antibody response but do develop cellular immunity. Whether these different patterns predict susceptibility or resistance to CMV-induced disease remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369706     DOI: 10.1093/intimm/13.6.785

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  15 in total

1.  CMV antigen-specific CD4+ and CD8+ T cell IFNgamma expression and proliferation responses in healthy CMV-seropositive individuals.

Authors:  Elizabeth Sinclair; Douglas Black; C Lorrie Epling; Alexander Carvidi; Steven Z Josefowicz; Barry M Bredt; Mark A Jacobson
Journal:  Viral Immunol       Date:  2004       Impact factor: 2.257

2.  Physical function impairment of older, HIV-infected adults is associated with cytomegalovirus immunoglobulin response.

Authors:  Kristine M Erlandson; Amanda A Allshouse; Eric Rapaport; Brent E Palmer; Cara C Wilson; Adriana Weinberg; Samantha MaWhinney; Thomas B Campbell
Journal:  AIDS Res Hum Retroviruses       Date:  2015-07-08       Impact factor: 2.205

3.  Simultaneous monitoring of cytomegalovirus-specific antibody and T-cell levels in seropositive heart transplant recipients.

Authors:  Javier Carbone; Nallibe Lanio; Antonio Gallego; Florian Kern; Joaquin Navarro; Patricia Muñoz; Roberto Alonso; Pilar Catalán; Juan Fernández-Yáñez; Jesús Palomo; Manuel Ruiz; Eduardo Fernández-Cruz; Elizabeth Sarmiento
Journal:  J Clin Immunol       Date:  2012-02-29       Impact factor: 8.317

4.  Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV.

Authors:  Afsar Rahbar; Inti Peredo; Nina Wolmer Solberg; Chato Taher; Mensur Dzabic; Xinling Xu; Petra Skarman; Olesja Fornara; Charlotte Tammik; Koon Yaiw; Vanessa Wilhelmi; Alice Assinger; Giuseppe Stragliotto; Cecilia Söderberg-Naucler
Journal:  Oncoimmunology       Date:  2015-02-25       Impact factor: 8.110

5.  Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study.

Authors:  George C Wang; Wen Hong L Kao; Peter Murakami; Qian-Li Xue; Roger B Chiou; Barbara Detrick; John F McDyer; Richard D Semba; Vincenzo Casolaro; Jeremy D Walston; Linda P Fried
Journal:  Am J Epidemiol       Date:  2010-04-16       Impact factor: 4.897

6.  Efficient human cytomegalovirus reactivation is maturation dependent in the Langerhans dendritic cell lineage and can be studied using a CD14+ experimental latency model.

Authors:  Margaret M Huang; Verity G Kew; Kevin Jestice; Mark R Wills; Matthew B Reeves
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

7.  Cytomegalovirus-specific responses of CD38⁺ memory T cells are skewed towards IFN-γ and dissociated from CD154 in HIV-1 infection.

Authors:  Gustavo Olvera-García; Enrique Espinosa; Scott F Sieg; Michael M Lederman
Journal:  AIDS       Date:  2014-01-28       Impact factor: 4.177

8.  Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT.

Authors:  Holden T Maecker; James Moon; Sonny Bhatia; Smita A Ghanekar; Vernon C Maino; Janice K Payne; Kristine Kuus-Reichel; Jennie C Chang; Amanda Summers; Timothy M Clay; Michael A Morse; H Kim Lyerly; Corazon DeLaRosa; Donna P Ankerst; Mary L Disis
Journal:  BMC Immunol       Date:  2005-07-18       Impact factor: 3.615

9.  Associations of social environment, socioeconomic position and social mobility with immune response in young adults: the Jerusalem Perinatal Family Follow-Up Study.

Authors:  Gabriella M Lawrence; Yehiel Friedlander; Ronit Calderon-Margalit; Daniel A Enquobahrie; Jonathan Yinhao Huang; Russell P Tracy; Orly Manor; David S Siscovick; Hagit Hochner
Journal:  BMJ Open       Date:  2017-12-21       Impact factor: 2.692

Review 10.  Controlling cytomegalovirus: helping the immune system take the lead.

Authors:  Patrick J Hanley; Catherine M Bollard
Journal:  Viruses       Date:  2014-05-27       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.